These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23010347)

  • 1. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
    Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
    Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
    Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
    Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
    FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
    Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L
    Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.
    Zhang L; Yang F; Yuan JH; Yuan SX; Zhou WP; Huo XS; Xu D; Bi HS; Wang F; Sun SH
    Carcinogenesis; 2013 Mar; 34(3):577-86. PubMed ID: 23222811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.
    Xu J; Li X; Yang H; Chang R; Kong C; Yang L
    Cancer; 2013 Jun; 119(12):2247-57. PubMed ID: 23564492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
    Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J
    Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.
    Wang XQ; Zhang W; Lui EL; Zhu Y; Lu P; Yu X; Sun J; Yang S; Poon RT; Fan ST
    Int J Cancer; 2012 Aug; 131(3):E163-72. PubMed ID: 22052196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer].
    Jia WD; Wang W; Tang ZY; Xu GL; Sun HC; Zhou HJ
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):241-5. PubMed ID: 19615273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
    Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N
    Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
    Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis.
    Zheng W; Yao M; Wu M; Yang J; Yao D; Wang L
    J Transl Med; 2020 Feb; 18(1):81. PubMed ID: 32059741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
    Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin.
    Chen D; Wang Y; Zhang K; Jiao X; Yan B; Liang J
    Int J Mol Sci; 2012; 13(8):10594-10607. PubMed ID: 22949882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.